HARP — Harpoon Therapeutics Share News
0.000.00%
Last trade - 00:00- $492.35m
- $469.57m
- $31.92m
Brief: Harpoon Therapeutics Reports Q3 Revenue Of $4.5 Mln
Harpoon Therapeutics Inc expected to post a loss of 52 cents a share - Earnings Preview
Harpoon Therapeutics Inc expected to post a loss of 52 cents a share - Earnings Preview
Brief: Harpoon Therapeutics Announces Change To Management Team And Board Of Directors
Harpoon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Harpoon Therapeutics Says Net Loss For Q2 Ended June 30, 2021 Was $16.8 Million
Harpoon Therapeutics Inc expected to post a loss of 43 cents a share - Earnings Preview
Harpoon Therapeutics Inc expected to post a loss of 43 cents a share - Earnings Preview
Harpoon Therapeutics Inc expected to post a loss of 43 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Biogen, Middleby, Vera Therapeutics
Brief: Harpoon Provides Progress Update For TriTAC Clinical Programs And ProTriTAC Platform
U.S. STOCKS ON THE MOVE-Biogen, Broadcom, GM, gold miners
Brief: Harpoon Therapeutics Presents Updated Interim Clinical Data For The Psma-Targeting Tritac® Hpn424 At The 2021 Asco Annual Meeting
U.S. STOCKS ON THE MOVE-Tesla, Tapestry, Comstock, Broadcom
Harpoon Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Harpoon Therapeutics Reports First Quarter 2021 Financial Results And Provides Corporate Update
Harpoon Therapeutics Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: Harpoon Therapeutics Says On April 23, Delaware Court Issued Memorandum Opinion
U.S. RESEARCH ROUNDUP-Bluebird Bio, Mission Produce, Sally Beauty Holdings